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Abstract
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The aim of this study was to determine the feasibility of using contrast-enhanced ultrasound
(CEUS) evaluation to determine thoracic duct (TD) outlet patency. Nine patients referred
for lymphatic imaging and intervention underwent percutaneous intranodal ultrasound contrast
injection and conventional lymphangiography (CL). Eight of 9 patients had a patent TD by CEUS
and CL. One patient did not have a patent TD. There was 100% agreement between CEUS and
CL. These results suggest that CEUS is an imaging modality that might be as accurate as CL in
determining TD patency.
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Determining thoracic duct (TD) outlet patency is an important branch point in the algorithm
for managing patients with lymphatic disorders. Lymphatic flow into the systemic venous
system might be limited owing to abnormal lymphatic development, increased central
venous pressure, or (acquired) obstruction at the level of the TD outlet. When medical
management fails, a patient might be a candidate for lymphatic procedures, such as
innominate vein rerouting, or a lymphovenous anastomosis to enhance lymphatic flow (1–4).
However, the strategy employed is dependent not only on the underlying diagnosis but also
on the patency of the TD outlet.
Several advances in lymphatic imaging techniques have improved visualization of anatomy
and flow. Pedal lymphangiography and pedal lymphoscintigraphy, which were among the
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first imaging modalities, were time-consuming, challenging, and limited in their ability to
visualize central lymphatic flow (5–7). Intranodal lymphangiography has now emerged as
an imaging technique to visualize the central lymphatic system because it allows bypassing
of the lower extremities (8). The development of intranodal dynamic contrast-enhanced
magnetic resonance lymphangiography (DCMRL) has allowed for improved spatial and
temporal resolution (9–11) and is rapidly being adopted as a minimally invasive method to
access central lymphatic anatomy and flow. However, there are still cases where the TD
outlet patency is uncertain and the use of conventional lymphangiography (CL) is necessary.
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CL, which is the gold standard, is still time-consuming, might involve a long anesthetic
time, and involves radiation exposure (7,12). Previously, high-resolution ultrasound has
been used to determine the patency of the TD outlet in healthy adults, but there has
been limited experience using this technique to interrogate the TD outlet in children with
suspected lymphatic disorders (13). Thus, the purpose of this study was to determine
whether contrast-enhanced ultrasound (CEUS) could be used to assess TD patency after
percutaneous intranodal ultrasound contrast injection.

MATERIALS AND METHODS
Patient Selection
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The institutional review board at the study center approved this retrospective study
of consecutive patients who presented for clinically indicated lymphatic imaging and
intervention between November 1, 2017, and September 30, 2018. All patients who
underwent DCMRL as part of planning for lymphatic intervention were eligible to undergo
CEUS. There were 9 patients (7 males) with a mean age of 3.5 years (range, 4 months
to 13.8 years) (Table 1). Seven of nine (78%) had chylothorax, 1 had protein-losing
enteropathy, 1 had anasarca, and 1 had plastic bronchitis. Also, 78% (7/9) had congenital
heart disease, and 1 had cardiomyopathy. Descriptive statistics were used to report patient
demographics. All patients had clinical evidence of lymphatic dysfunction.
Imaging Technique
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Imaging was performed in an XMR suite that combines a magnetic resonance imaging
scanner with a cardiac catheterization laboratory. Patients first underwent DCMRL, which
has been previously described (9). Briefly, bilateral inguinal lymph nodes (1 on each side)
were accessed in the catheterization lab under ultrasound guidance using a 25-gauge spinal
needle. A small amount of water-soluble iodinated contrast agent was injected to confirm
positioning of the needle in the lymph node by fluoroscopy. The needle was then secured in
place with Tegaderm (3M, Maplewood, Minnesota). DCMRL was then undertaken using a
gadolinium dose of 0.2 mmol/kg diluted 1:1 with normal saline injected at a rate of 0.5–1.0
ml/minute.
After DCMRL completion, the patient was returned to the catheterization lab. To perform
ultrasound imaging, the patient was in the supine position with the neck slightly extended.
The left (or right) internal jugular vein was first visualized just above the clavicle at an
oblique angle; an L12 probe was then rotated rightward (or leftward) parallel to the clavicle.
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The TD was visualized draining into the left (or right) venous angle or in one of the
internal or subclavian veins. Using the inguinal needles, 3 ml of contrast (sulfur hexafluoride
lipid-type A microspheres; Bracco Diagnostics Inc, Monroe Township, New Jersey) was
delivered over 20–30 seconds followed by 3 ml of normal saline. Ultrasound imaging (Epiq;
Philips, Amsterdam, Netherlands) of the left or right neck was initiated at the time of
contrast injection and continued between 3 and 5 minutes or until contrast appeared. If it
was deemed that an intervention was appropriate, the patient then underwent CL.
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A cardiologist with specialized lymphatic interventional training performed the CEUS. The
cardiologist and an interventional cardiologist with over 9 years of experience performed
the lymphangiography. Two blinded and independent pediatric radiologists with over 5 years
of experience in lymphatic and CEUS imaging reviewed the data to evaluate TD patency.
TD patency was determined by visualization of lymphatic contrast passing into the venous
system in the left or right neck. Results were correlated with DCMRL and CL. The DCMRL
was interpreted separately by 1 of the blinded radiologists. Neither radiologist performed the
procedures.

RESULTS
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Of the 9 cases, the contrast was seen entering the vein through the TD outlet in 8 cases and
was therefore classified as patent (Fig 1a,b and Video 1 [available online on the article’s
Supplemental Material page at www.jvir.org]). In 1 case, no contrast was seen entering the
venous system and was therefore classified as not patent (Fig 2a). There was agreement
between both CEUS readers on all cases. DCMRL was performed in all patients (Table 2).
The TD was visualized by DCMRL in all cases, but the TD outlet could not be directly
visualized to assess patency (Fig 1c). The TD was noted to be moderately dilated in 3 cases.
The TD was mildly tortuous in 5 cases and moderately tortuous in 4 cases All patients were
assessed for the presence of contrast reflux into the neck lymphatics, and only 1 of 9 patients
had significant reflux; this patient had a patent TD. In none of the patients could patency of
the TD be determined by DCMRL. All patients also had conventional lymphangiography. Of
these cases, the TD outlet was patent in 8 of 9 by CL (Fig 2b). There was 100% agreement
between the findings on CEUS and CL.

DISCUSSION
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Over the last several years, advances in imaging of the lymphatic system have led
to improvements in efficiency of data acquisition and diagnostic accuracy. Specifically,
DCMRL has enabled gathering of detailed information regarding anatomy and central
lymphatic flow that has aided in determining which interventional technique is most
appropriate for the patient (2,7,9). However, assessing patency of the TD on DCMRL is
challenging, as the TD outlet cannot be directly visualized. There are secondary signs that
the TD might be patent, such as a small duct with normal caliber, and secondary signs
that it is not patent, such as a large duct with multiple collateral channels. The temporal
resolution of DCMRL is another limitation, as it does not allow for direct visualization
of gadolinium entering the venous system—a task that is made more challenging by
rapid dilution of gadolinium in the venous system. Although the patient’s underlying
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diagnosis and anatomy is critical in defining the best strategy (embolization, lymphovenous
anastomosis, or innominate vein rerouting), it is imperative to determine patency before
considering advanced methods of decompression.
This study demonstrates that CEUS may be used as a method to identify TD patency. CL is
currently the gold standard; however, it requires patients to undergo a prolonged anesthetic
procedure and more radiation. Other limitations to CL include the increased risk of bleeding
and infection, especially when transabdominal access is necessary to demonstrate the TD.
Furthermore, the use of Lipiodol is problematic in certain populations, including those with
right to left shunting, which can lead to strokes or central lymphatic flow disorders, as they
do not tolerate embolization/sclerosis that can be induced by Lipiodol injection (14,15).
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Ultrasound imaging of the TD in adults has been previously described. In a study by Seeger
et al (13) of 585 patients, ultrasound imaging was able to assess the anatomy and function of
the TD in 96% of cases. The use of contrast in a small subset of patients with liver cirrhosis
was used to demonstrate differentiation between the TD and the surrounding vessels.
The work currently presented suggests that CEUS might similarly be used in children to
assess TD patency. It offers an imaging modality with less radiation and shorter anesthetic
time and might provide a less invasive and faster method of identifying function. At the
authors’ institution, CEUS is frequently performed after DCMRL, as this modality rarely
demonstrates outlet patency. Lymphangiography is performed if the diagnosis and findings
on imaging suggest that an intervention is possible.
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This retrospective study had limitations owing to a small sample population and procedures
being performed at a single center. Furthermore, there were few patients who had TDs
that were not patent, and thus the specificity of CEUS to determine TD patency is limited.
Another consideration is that, in the setting of an obstructed TD, small collaterals might
form that allow contrast to enter the vein. To mitigate this, the largest connection of the TD
to the vein was identified via ultrasound. Another limitation was that not all patients had CL.
Wider use of CEUS might lead to further assessment of this technique.
In conclusion, this exploratory study suggests that CEUS might be a less invasive method
of assessing TD outlet patency either as a standalone technique or in conjunction with
DCMRL. Further investigations are needed, but it might provide an opportunity to eliminate
the need of CL in cases where no percutaneous intervention is needed.
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Refer to Web version on PubMed Central for supplementary material.

ABBREVIATIONS
CEUS

contrast-enhanced ultrasound

CL

conventional lymphangiography

DCMRL

dynamic contrast-enhanced magnetic resonance lymphangiography
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TD

thoracic duct
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Figure 1.
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(a) Two-dimensional ultrasound of the left internal jugular vein (arrowhead) and proximal
innominate vein (arrow) before contrast injection. (b) CEUS of the left neck reveals passage
of contrast injected into the lymphatic system into the left internal jugular vein (arrow)
extending into the innominate vein (arrowhead), confirming patency of the TD outlet. (c)
Magnetic resonance lymphography in the same patient as in Figure 1a, demonstrating the
TD (arrow) and lymphatic network. Because of the complex and abnormal network, it is not
possible to determine patency of the TD.
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Figure 2.

Author Manuscript

(a) CEUS of the left neck in this patient reveals lack of passage of contrast into the internal
jugular vein (arrows) after injection into the lymphatic system. (b) CL of the TD (arrow)
in the same patient as in Figure 2a with no venous connection (arrowhead), consistent with
occluded TD outlet.
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Patient Characteristics
Sex

Diagnosis

Lymphatic diagnosis

Surgical history

1

Age (y)
6.7

M

Ebstein anomaly, PA

Chylothorax

Fenestrated Fontan

2

5.7

M

HLHS

Chylothorax

Fenestrated Fontan

3

3.6

M

TGA, PA

Chylothorax

Heart transplant

4

14.6

M

Tricuspid atresia, PA

PLE

Fenestrated Fontan

5

13.7

F

Aortic atresia

Plastic bronchitis

Fenestrated Fontan

6

0.5

M

TGA

Chylothorax

ASO

7

0.4

F

PDA

Anasarca

PDA occlusion

8

0.4

M

No CHD/idiopathic

Chylous ascites

None

9

0.5

M

No CHD/idiopathic

Chylothorax

None
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ASO = arterial switch; CHD = congenital heart disease; HLHS = hypoplastic left heart syndrome; PA = pulmonary atresia; PDA = patent ductus
arteriosus; PLE = protein-losing enteropathy; TGA = transposition of the great arteries.
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Mildly tortuous TD
Mildly tortuous TD

Moderately dilated and tortuous TD

7

8

9

None

None

Mild

Mild

Moderate

Mild

Mild

Moderate

Severe

Reflux into neck lymphatics

Y

Y

Y

Y

Y

Y

Y

Y

Y

TD seen

No significant dilation or tortuosity of TD.

No significant dilation or tortuosity of TD.

No significant dilation or tortuosity of TD.

Dilated and tortuous TD

Massively dilated and tortuous TD

Mildly dilated TD

Dilated and tortuous TD

Dilated and tortuous TD

Severely dilated TD

CL findings

Conventional lymphangiography

NA = not applicable, as study was not performed or patency was unable to be assessed via the imaging modality; TD = thoracic duct.

Mildly dilated and tortuous TD

Mildly dilated and moderately tortuous TD

6

Moderately dilated TD

5

Mildly dilated and tortuous TD

4

2

3

Moderately dilated and tortuous TD

Mildly dilated and moderately tortuous TD

1

Findings

Dynamic contrast MR lymphangiography
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Patient

Author Manuscript

Imaging Findings

Y

Y

Y

N

Y

Y

Y

Y

Y

TD patent

Y

Y

Y

N

Y

Y

Y

Y

Y

TD patent

Contrast-enhanced ultrasound
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